With a clean beat on both revenue and EPS, guidance raised, a $1.0B buyback expansion, and Adj EBITDA margins hitting 46% (up 400 bps), the quarter confirms accelerating operating leverage in the HSA flywheel. The stock likely gaps up on Tuesday open. Post-earnings drift could persist given the strong beat/raise narrative and 90% analyst bullish consensus. Key level to watch: prior quarter's report saw +23% YoY Adj EBITDA growth; this quarter delivered +17% on tougher comps but with broader margin expansion.
Price Chart
Executive Summary
HealthEquity (HQY) reported FQ1 2026 revenue of $354.6M (+7% YoY) and non-GAAP EPS of $1.24, beating consensus estimates of $348.7M and $1.19 respectively. The company raised fiscal 2027 revenue guidance to $1.410B-$1.420B (from $1.405B-$1.415B previously), increased its stock repurchase authorization by $1.0B, and expanded Adjusted EBITDA margins by 400 bps to 46%, signaling accelerating operating leverage.
Key Financial Metrics
Key Facts
- Revenue $354.6M, +7% YoY vs consensus $348.7M (beat)
- Non-GAAP EPS $1.24, +28% YoY vs consensus $1.19 (beat by 4.2%)
- GAAP net income $69.4M, +29% YoY; GAAP diluted EPS $0.82, +34% YoY
- Adjusted EBITDA $164.5M, +17% YoY; margin expanded to 46% from 42%
- FY2027 revenue guidance raised to $1.410B-$1.420B from $1.405B-$1.415B
- Non-GAAP EPS guidance raised to $4.66-$4.73 from $4.56-$4.65
- Board authorized additional $1.0B in share repurchases (on top of remaining $177.7M)
- Total HSA Assets grew 19% YoY to $37.1B; HSAs with investments up 18% YoY
- Operating cash flow $97.5M, up 51% YoY
- Net debt reduced by ~$15M sequentially
Financial Impact
Revenue beat consensus by ~1.7% ($354.6M vs $348.7M); EPS beat consensus by ~4.2% ($1.24 vs $1.19). Guidance raised ~0.4% at midpoint. $1.0B buyback authorization added on top of existing $177.7M remaining. Quarterly net income improved 29% YoY.
Risk Factors
- Revenue growth decelerated to 7% from 9% in FY2026, though largely expected after record new HSA sales year
- Custodial revenue sensitive to interest rate trajectory — declining rates would pressure a key growth driver
- AOCI grew more negative (-$31.8M vs -$5.7M at year-end) from cash flow hedge losses, though non-cash
- Stock buyback at elevated prices reduces future float but may signal management believes valuation remains attractive
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001428336-26-000027 |
| Document: hqy-20260528.htm | 0001428336-26-000027 |
| Document: 0001428336-26-000027-index-headers.html | 0001428336-26-000027 |
| Document: 0001428336-26-000027-index.html | 0001428336-26-000027 |
| Document: 0001428336-26-000027.txt | 0001428336-26-000027 |
| 8-K Data (Synthetic) | 0001428336-26-000027 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | 8-K | $93.39 $88.60 | ▼ −5.13% | ▼ −4.62% | $89.98 (−3.65%) |
Aug 27, 2026 5w ago | Press Release | $93.39 $88.60 | ▼ −5.13% | ▼ −4.62% | $89.98 (−3.65%) |
Aug 3, 2026 8w ago | Press Release | $104.97 $97.00 | ▼ −7.59% | ▼ −6.35% | $89.98 (−14.28%) |
Jun 2, 2026 17w ago | Insider Cluster | $85.21 $95.31 | ▲ +11.85% | ▲ +12.85% | $89.98 (+5.60%) |
May 28, 2026 18w ago | 8-K | $87.99 $87.81 | ▼ −0.20% | ▲ +1.59% | $89.98 (+2.26%) |
May 28, 2026 18w ago | Press Release | $87.99 $87.81 | ▼ −0.20% | ▲ +1.59% | $89.98 (+2.26%) |
May 8, 2026 20w ago | 8-K | $81.65 $89.23 | ▲ +9.28% | ▲ +9.59% | $89.98 (+10.20%) |
Mar 17, 2026 28w ago | Press Release | $79.57 $84.53 | ▲ +6.23% | ▲ +0.19% | $89.98 (+13.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access